{"id":4124,"date":"2023-06-02T14:58:00","date_gmt":"2023-06-02T18:58:00","guid":{"rendered":"https:\/\/neoaptamers.com\/?p=4124"},"modified":"2026-04-13T14:57:18","modified_gmt":"2026-04-13T18:57:18","slug":"why-has-neoventures-succeeded-as-an-aptamer-development-company","status":"publish","type":"post","link":"https:\/\/neoaptamers.com\/es\/why-has-neoventures-succeeded-as-an-aptamer-development-company\/","title":{"rendered":"Why has NeoVentures succeeded as an Aptamer development company?"},"content":{"rendered":"

NeoVentures was formed as an aptamer development company in June of 2002, and founded on a very simple principle. Businesses that create real sustainable value for their clients succeed. This does not always seem to be case as we have all seen biotechnology companies that are much more about marketing than substance raise investment capital and grow rapidly. Now that NeoVentures has been in the business over twenty years, we have had lots of experience observing such companies, they invariably crash.<\/p>\n

We have had to learn a lot about aptamers and about the realities of the healthcare business. Learning starts with understanding what are the real problems that you, our client face in trying to commercialize products. In all cases you are trying to build a better mousetrap. You want diagnostics that are faster, simpler and less expensive than what exists. You want more targeted drug delivery so that the side effects are minimized, you want to re-imagine how cells work so that they respond and overcome disease more effectively, and you need higher throughput analysis in drug development to identify new candidates faster at less expense. Simple, right?<\/p>\n

Based on this, we have learned that traditional aptamer development approaches were not adequate. You need aptamers that do not bind to abundant proteins in biological matrices. We have tried, but this was not possible with SELEX. That is why we invented our Neomer approach, utilizing the same 4.29 billion sequences in every selection. There was a need to develop specificity beyond what could be measured with binding assays. The Neomer approach enables this by allowing us to screen the 10,000 best aptamers for your target for their response in selection against albumin, IgGs and mucin. We could not have created this platform back in 2002. We needed to build on improvements in next generation sequencing capacity, computing power, and machine learning. Our current success and more importantly our future success depends on our computing capacity and our bioinformatics team.<\/p>\n

With better aptamers comes better applications. The Neomer platform has enabled us to build a high throughput screening system to support fluorescent switch aptamers in application to biomanufacturing and drug development. Waiting nine to twelve months for antibody development is not satisfactory, we need to develop cut and paste aptamer based applications in three months. We have learned how to select aptamers for drug delivery that will induce endocytosis, and aptamers to block virus infection by not inducing endocytosis.<\/p>\n

We could not imagine the future applications that you are developing now for improvements in healthcare when we started NeoVentures. The progress that we have made together is humbling, and the future prospects of what we can help you achieve are exhilarating. At NeoVentures we are leaning into the future with the use of ChatGPT, advances in electrochemistry, CRISPR, and the need for more personalized healthcare. We lean into the future together with partners with whom we have developed successful relationships, and we look forward to meeting new people with new ideas and opportunities. We look forward to the next twenty years of aptamers actually making a significant impact on health and wellness throughout the world.<\/p>\n

Learn more by getting in touch with our team today. Contact us on our website now.<\/a><\/p>","protected":false},"excerpt":{"rendered":"

NeoVentures was formed as an aptamer development company in June of 2002, and founded on a very simple principle. Businesses that create real sustainable value for their clients succeed. This does not always seem to be case as we have all seen biotechnology companies that are much more about marketing than substance raise investment capital… Leer m\u00e1s »Why has NeoVentures succeeded as an Aptamer development company?<\/span><\/a><\/p>","protected":false},"author":2,"featured_media":4125,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"off","neve_meta_content_width":70,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","footnotes":""},"categories":[8,18],"tags":[],"class_list":["post-4124","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-aptamers","category-neomers"],"yoast_head":"\nWhy has NeoVentures succeeded as an Aptamer development company? | Neoaptamers.com<\/title>\n<meta name=\"description\" content=\"NeoVentures was formed as an aptamer development company in 2002, and founded on a simple principle. Businesses that create real sustainable value for their clients succeed.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/neoaptamers.com\/es\/why-has-neoventures-succeeded-as-an-aptamer-development-company\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Why has NeoVentures succeeded as an Aptamer development company? | Neoaptamers.com\" \/>\n<meta property=\"og:description\" content=\"NeoVentures was formed as an aptamer development company in 2002, and founded on a simple principle. Businesses that create real sustainable value for their clients succeed.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/neoaptamers.com\/es\/why-has-neoventures-succeeded-as-an-aptamer-development-company\/\" \/>\n<meta property=\"og:site_name\" content=\"neoaptamers\" \/>\n<meta property=\"article:published_time\" content=\"2023-06-02T18:58:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-13T18:57:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/06\/Images-for-Neomers.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"750\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Gregory Penner\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Gregory Penner\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/why-has-neoventures-succeeded-as-an-aptamer-development-company\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/why-has-neoventures-succeeded-as-an-aptamer-development-company\\\/\"},\"author\":{\"name\":\"Gregory Penner\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/person\\\/641d6a3e016e13414b8d0d0ffd5847ad\"},\"headline\":\"Why has NeoVentures succeeded as an Aptamer development company?\",\"datePublished\":\"2023-06-02T18:58:00+00:00\",\"dateModified\":\"2026-04-13T18:57:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/why-has-neoventures-succeeded-as-an-aptamer-development-company\\\/\"},\"wordCount\":545,\"publisher\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/why-has-neoventures-succeeded-as-an-aptamer-development-company\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Images-for-Neomers.png\",\"articleSection\":[\"Aptamers\",\"Neomer\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/why-has-neoventures-succeeded-as-an-aptamer-development-company\\\/\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/why-has-neoventures-succeeded-as-an-aptamer-development-company\\\/\",\"name\":\"Why has NeoVentures succeeded as an Aptamer development company? | Neoaptamers.com\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/why-has-neoventures-succeeded-as-an-aptamer-development-company\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/why-has-neoventures-succeeded-as-an-aptamer-development-company\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Images-for-Neomers.png\",\"datePublished\":\"2023-06-02T18:58:00+00:00\",\"dateModified\":\"2026-04-13T18:57:18+00:00\",\"description\":\"NeoVentures was formed as an aptamer development company in 2002, and founded on a simple principle. Businesses that create real sustainable value for their clients succeed.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/why-has-neoventures-succeeded-as-an-aptamer-development-company\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/neoaptamers.com\\\/why-has-neoventures-succeeded-as-an-aptamer-development-company\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/why-has-neoventures-succeeded-as-an-aptamer-development-company\\\/#primaryimage\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Images-for-Neomers.png\",\"contentUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Images-for-Neomers.png\",\"width\":1000,\"height\":750},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/why-has-neoventures-succeeded-as-an-aptamer-development-company\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/neoaptamers.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Why has NeoVentures succeeded as an Aptamer development company?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#website\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/\",\"name\":\"Neoaptamers.com\",\"description\":\"Neoventures Biotechnology Inc.\",\"publisher\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/neoaptamers.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\",\"name\":\"NeoVentures Biotechnology Inc.\",\"alternateName\":\"NVB\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png\",\"contentUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png\",\"width\":500,\"height\":500,\"caption\":\"NeoVentures Biotechnology Inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/neoventures-biotechnology-inc-\\\/\",\"https:\\\/\\\/www.reddit.com\\\/user\\\/NeoVenturesBiotech\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@neoaptamers7964\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/person\\\/641d6a3e016e13414b8d0d0ffd5847ad\",\"name\":\"Gregory Penner\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g\",\"caption\":\"Gregory Penner\"},\"description\":\"Dr. Gregory Penner academic training was a blend of very practical plant breeding theory combined with molecular biology. He has used this blend of biology and mathematics to first develop and lead a cereal biotechnology research team with the government of Canada and subsequently as a global research leader with Monsanto Inc. He has been a thought leader in aptamer development globally for the last twenty years as CEO and President of NeoVentures. \u00a0He has led this company to financial stability without outside investment with an integrated approach to aptamer discovery and commercialization. In 2015, he co- founded a second company, NeoNeuro in Paris France, focused on an innovative approach to identify Aptamarkers for complex diseases. Connect with Dr. Penner on LinkedIn or for company updates, follow NeoVentures. Click here to get in touch with our team.\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Why has NeoVentures succeeded as an Aptamer development company? | Neoaptamers.com","description":"NeoVentures was formed as an aptamer development company in 2002, and founded on a simple principle. Businesses that create real sustainable value for their clients succeed.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/neoaptamers.com\/es\/why-has-neoventures-succeeded-as-an-aptamer-development-company\/","og_locale":"es_ES","og_type":"article","og_title":"Why has NeoVentures succeeded as an Aptamer development company? | Neoaptamers.com","og_description":"NeoVentures was formed as an aptamer development company in 2002, and founded on a simple principle. Businesses that create real sustainable value for their clients succeed.","og_url":"https:\/\/neoaptamers.com\/es\/why-has-neoventures-succeeded-as-an-aptamer-development-company\/","og_site_name":"neoaptamers","article_published_time":"2023-06-02T18:58:00+00:00","article_modified_time":"2026-04-13T18:57:18+00:00","og_image":[{"width":1000,"height":750,"url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/06\/Images-for-Neomers.png","type":"image\/png"}],"author":"Gregory Penner","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Gregory Penner","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/neoaptamers.com\/why-has-neoventures-succeeded-as-an-aptamer-development-company\/#article","isPartOf":{"@id":"https:\/\/neoaptamers.com\/why-has-neoventures-succeeded-as-an-aptamer-development-company\/"},"author":{"name":"Gregory Penner","@id":"https:\/\/neoaptamers.com\/#\/schema\/person\/641d6a3e016e13414b8d0d0ffd5847ad"},"headline":"Why has NeoVentures succeeded as an Aptamer development company?","datePublished":"2023-06-02T18:58:00+00:00","dateModified":"2026-04-13T18:57:18+00:00","mainEntityOfPage":{"@id":"https:\/\/neoaptamers.com\/why-has-neoventures-succeeded-as-an-aptamer-development-company\/"},"wordCount":545,"publisher":{"@id":"https:\/\/neoaptamers.com\/#organization"},"image":{"@id":"https:\/\/neoaptamers.com\/why-has-neoventures-succeeded-as-an-aptamer-development-company\/#primaryimage"},"thumbnailUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/06\/Images-for-Neomers.png","articleSection":["Aptamers","Neomer"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/neoaptamers.com\/why-has-neoventures-succeeded-as-an-aptamer-development-company\/","url":"https:\/\/neoaptamers.com\/why-has-neoventures-succeeded-as-an-aptamer-development-company\/","name":"Why has NeoVentures succeeded as an Aptamer development company? | Neoaptamers.com","isPartOf":{"@id":"https:\/\/neoaptamers.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/neoaptamers.com\/why-has-neoventures-succeeded-as-an-aptamer-development-company\/#primaryimage"},"image":{"@id":"https:\/\/neoaptamers.com\/why-has-neoventures-succeeded-as-an-aptamer-development-company\/#primaryimage"},"thumbnailUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/06\/Images-for-Neomers.png","datePublished":"2023-06-02T18:58:00+00:00","dateModified":"2026-04-13T18:57:18+00:00","description":"NeoVentures was formed as an aptamer development company in 2002, and founded on a simple principle. Businesses that create real sustainable value for their clients succeed.","breadcrumb":{"@id":"https:\/\/neoaptamers.com\/why-has-neoventures-succeeded-as-an-aptamer-development-company\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/neoaptamers.com\/why-has-neoventures-succeeded-as-an-aptamer-development-company\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/neoaptamers.com\/why-has-neoventures-succeeded-as-an-aptamer-development-company\/#primaryimage","url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/06\/Images-for-Neomers.png","contentUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/06\/Images-for-Neomers.png","width":1000,"height":750},{"@type":"BreadcrumbList","@id":"https:\/\/neoaptamers.com\/why-has-neoventures-succeeded-as-an-aptamer-development-company\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/neoaptamers.com\/"},{"@type":"ListItem","position":2,"name":"Why has NeoVentures succeeded as an Aptamer development company?"}]},{"@type":"WebSite","@id":"https:\/\/neoaptamers.com\/#website","url":"https:\/\/neoaptamers.com\/","name":"Neoaptamers.com","description":"Neoventures Biotechnology Inc.","publisher":{"@id":"https:\/\/neoaptamers.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/neoaptamers.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/neoaptamers.com\/#organization","name":"NeoVentures Biotechnology Inc.","alternateName":"NVB","url":"https:\/\/neoaptamers.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/neoaptamers.com\/#\/schema\/logo\/image\/","url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2024\/07\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png","contentUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2024\/07\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png","width":500,"height":500,"caption":"NeoVentures Biotechnology Inc."},"image":{"@id":"https:\/\/neoaptamers.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/neoventures-biotechnology-inc-\/","https:\/\/www.reddit.com\/user\/NeoVenturesBiotech\/","https:\/\/www.youtube.com\/@neoaptamers7964"]},{"@type":"Person","@id":"https:\/\/neoaptamers.com\/#\/schema\/person\/641d6a3e016e13414b8d0d0ffd5847ad","name":"Gregory Penner","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g","caption":"Gregory Penner"},"description":"Dr. Gregory Penner academic training was a blend of very practical plant breeding theory combined with molecular biology. He has used this blend of biology and mathematics to first develop and lead a cereal biotechnology research team with the government of Canada and subsequently as a global research leader with Monsanto Inc. He has been a thought leader in aptamer development globally for the last twenty years as CEO and President of NeoVentures. \u00a0He has led this company to financial stability without outside investment with an integrated approach to aptamer discovery and commercialization. In 2015, he co- founded a second company, NeoNeuro in Paris France, focused on an innovative approach to identify Aptamarkers for complex diseases. Connect with Dr. Penner on LinkedIn or for company updates, follow NeoVentures. Click here to get in touch with our team."}]}},"_links":{"self":[{"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/posts\/4124","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/comments?post=4124"}],"version-history":[{"count":2,"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/posts\/4124\/revisions"}],"predecessor-version":[{"id":4127,"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/posts\/4124\/revisions\/4127"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/media\/4125"}],"wp:attachment":[{"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/media?parent=4124"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/categories?post=4124"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/tags?post=4124"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}